Each number has its full source under its own list below.
Medicines authorised in the EU
4 medicines (authorised now). Newest first. Each links to its EMA page.
VacPertagen
Active substance: recombinant pertussis toxin;filamentous haemagglutinin
Abrysvo
Active substance: respiratory syncytial virus vaccine (bivalent, recombinant)
Thalidomide Lipomed
Active substance: thalidomide
Thalidomide BMS (previously Thalidomide Celgene)
Active substance: thalidomide
Source: European Medicines Agency, Centrally authorised human medicines (EPAR), authorised now. Retrieved 12 Nov 2026.
Benchmarks on maternal
Countries side by side on public measures for this topic.
Market reports on maternal
Adolescent Pregnancy Public Health Report
Worldwide · 2024–2034
View report Public HealthAfghan Population Health Public Health Report
Worldwide · 2024–2034
View report Public HealthAntenatal Care Coverage Public Health Report
Worldwide · 2024–2034
View report Public HealthBirth Spacing Public Health Report
Worldwide · 2024–2034
View report Medical DevicesBreast Pumps
Worldwide · 2024–2034
View report Public HealthCaesarean Section Access Public Health Report
Worldwide · 2024–2034
View reportFrom our blog
Women's Health Supplements: A Growing Focus
Anaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth…
Read
Iron Supplements and the Fight Against Anaemia
Iron supplements are the first line against anaemia. Why taking them is the hard part, and how the market is…
Read
Cord Blood Banking: Is It Worth It?
Doctors' groups such as ACOG support public cord blood donation, but say routine private banking is not…
ReadEU medicine approvals on related topics
Acuitas market sizes and forecasts are only in our full reports. How we use public data.